Associated Papers
Regulation of MYC by CARD14 in human epithelium is a determinant of epidermal homeostasis and disease.
DeVore SB et al.
Cell Reports, 2024
39110589 (PubMed )
Supplement: NIHMS2019535-supplement-1.pdf
Classification of domains in predicted structures of the human proteome.
Schaeffer RD et al.
Proceedings of the National Academy of Sciences of the United States of America, 2023
36917664 (PubMed )
Supplement: pnas.2214069120.sd02.xlsx › Dataset_S2
Association of CARD14 Single-Nucleotide Polymorphisms with Psoriasis.
Suleman S et al.
International Journal of Molecular Sciences, 2022
Two cases of CARD14-associated papulosquamous eruption from India.
Chiramel MJ et al.
Pediatric Dermatology, 2020
CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders.
Zotti T et al.
Frontiers in Immunology, 2018
Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease.
Israel L et al.
Frontiers in Immunology, 2018
CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E et al.
The Journal of Investigative Dermatology, 2017
CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.
Ammar M et al.
The British Journal of Dermatology, 2016
Variant analysis of CARD14 in a Chinese Han population with psoriasis vulgaris and generalized pustular psoriasis.
Qin P et al.
The Journal of Investigative Dermatology, 2014
24999592 (PubMed )
Supplement: jid2014269x1.pdf
De novo mutations in moderate or severe intellectual disability.
Hamdan FF et al.
Plos Genetics, 2014
25356899 (PubMed )
Supplement: pgen.1004772.s004.xlsx › 452.202
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
Jordan CT et al.
American Journal of Human Genetics, 2012
Select a paper to view details